Lawrence Hunsicker
Overview
Explore the profile of Lawrence Hunsicker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matas A, Helgeson E, Fieberg A, Leduc R, Gaston R, Kasiske B, et al.
Transplantation
. 2021 Mar;
106(2):358-368.
PMID: 33675321
Background: Delayed graft function (DGF) of a kidney transplant results in increased cost and complexity of management. For clinical care or a DGF trial, it would be ideal to accurately...
2.
Helgeson E, Mannon R, Grande J, Gaston R, Cecka M, Kasiske B, et al.
Am J Transplant
. 2020 Oct;
21(5):1866-1877.
PMID: 33052625
Inflammation in areas of fibrosis (i-IFTA) in posttransplant biopsies is part of the diagnostic criteria for chronic active TCMR (CA TCMR -- i-IFTA ≥ 2, ti ≥ 2, t ≥ ...
3.
Matas A, Helgeson E, Gaston R, Cosio F, Mannon R, Kasiske B, et al.
Am J Transplant
. 2020 Mar;
20(9):2509-2521.
PMID: 32185865
Inflammation in areas of fibrosis (i-IFTA) in posttransplant biopsy specimens has been associated with decreased death-censored graft survival (DC-GS). Additionally, an i-IFTA score ≥ 2 is part of the diagnostic...
4.
Gaston R, Fieberg A, Helgeson E, Eversull J, Hunsicker L, Kasiske B, et al.
Transplantation
. 2019 Oct;
104(7):1483-1490.
PMID: 31568212
Background: About half of late kidney allograft losses are attributed to death with function (DWF), a poorly characterized outcome. An ongoing question is whether DWF is a consequence of chronic...
5.
Suneja M, Kuppachi S, Katz D, Hunsicker L
Transplantation
. 2019 Mar;
103(12):2549-2557.
PMID: 30893290
Background: Increased use of pediatric deceased donor kidneys could enlarge the deceased donor kidney pool. Kidney transplant outcomes from small pediatric donors were compared with those from ideal kidney (IK)...
6.
Matas A, Fieberg A, Mannon R, Leduc R, Grande J, Kasiske B, et al.
Am J Transplant
. 2018 Dec;
19(5):1432-1443.
PMID: 30506642
The DeKAF study was developed to better understand the causes of late allograft loss. Preliminary findings from the DeKAF cross-sectional cohort (with follow-up < 20 months) have been published. Herein,...
7.
Gaston R, Fieberg A, Hunsicker L, Kasiske B, Leduc R, Cosio F, et al.
Am J Transplant
. 2017 Nov;
18(5):1158-1167.
PMID: 29139625
Beyond the first posttransplant year, 3% of kidney transplants fail annually. In a prospective, multicenter cohort study, we tested the relative impact of early versus late events on risk of...
8.
Eberlein M, Hunsicker L, Reed R
Am J Respir Crit Care Med
. 2016 Sep;
194(5):642-3.
PMID: 27585387
No abstract available.
9.
Dad T, Tighiouart H, Joseph A, Bostom A, Carpenter M, Hunsicker L, et al.
Am J Kidney Dis
. 2016 Mar;
68(2):277-286.
PMID: 26947217
Background: Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether aspirin may reduce the risk for CVD, death, and kidney failure outcomes is uncertain. Study...
10.
Carpenter M, John A, Weir M, Smith S, Hunsicker L, Kasiske B, et al.
J Am Soc Nephrol
. 2014 Mar;
25(7):1554-62.
PMID: 24627349
The optimal BP level in kidney transplant recipients remains uncertain. This post hoc analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial cohort assessed associations of...